Monoclonal antibody specific for IDH1 R132H mutation

IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraff...

Full description

Saved in:
Bibliographic Details
Main Authors: Capper, David (Author) , Zentgraf, Hanswalter (Author) , Balß, Jörg (Author) , Hartmann, Christian (Author) , Deimling, Andreas von (Author)
Format: Article (Journal)
Language:English
Published: 2 October 2009
In: Acta neuropathologica
Year: 2009, Volume: 118, Issue: 5, Pages: 599-601
ISSN:1432-0533
DOI:10.1007/s00401-009-0595-z
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00401-009-0595-z
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00401-009-0595-z
Get full text
Author Notes:David Capper, Hanswalter Zentgraf, Jörg Balss, Christian Hartmann, Andreas von Deimling
Description
Summary:IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.
Item Description:Gesehen am 14.09.2021
Physical Description:Online Resource
ISSN:1432-0533
DOI:10.1007/s00401-009-0595-z